NYSE:MED - Medifast Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $135.36 -0.95 (-0.70 %) (As of 03/19/2019 06:04 AM ET)Previous Close$136.31Today's Range$131.94 - $136.1752-Week Range$87.40 - $260.98Volume203,400 shsAverage Volume281,098 shsMarket Capitalization$1.61 billionP/E Ratio29.57Dividend Yield2.20%Beta0.64 ProfileDiscussionAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products. It offers bars, bites, pretzels, puffs, oatmeal and cereal crunch products, drinks, hearty choices, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by OPTAVIA, Flavors of Home, and Essential 1 brands. The company sells its products through various channels, including the Internet, call centers, independent health advisors, medical professionals, franchise weight loss clinics, and direct consumer marketing. As of December 31, 2017, it operated 16 franchised Medifast weight control centers in Arizona, California, Louisiana, Minnesota, and Wisconsin; and 18 reseller locations in California, Maryland, and Pennsylvania. The company was founded in 1980 and is headquartered in Baltimore, Maryland. Receive MED News and Ratings via Email Sign-up to receive the latest news and ratings for MED and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Miscellaneous food preparations & kindred products Sub-IndustryPersonal Products SectorConsumer Staples Current SymbolNYSE:MED Previous Symbol CUSIP58470H10 CIK910329 Webwww.medifast1.com Phone410-581-8042Debt Debt-to-Equity RatioN/A Current Ratio2.41 Quick Ratio1.77Price-To-Earnings Trailing P/E Ratio29.57 Forward P/E Ratio20.76 P/E Growth1.05 Sales & Book Value Annual Sales$501 million Price / Sales3.21 Cash Flow$5.0451 per share Price / Cash Flow26.83 Book Value$9.12 per share Price / Book14.84Profitability EPS (Most Recent Fiscal Year)$4.62 Net Income$55.79 million Net Margins11.14% Return on Equity51.04% Return on Assets34.23%Miscellaneous EmployeesN/A Outstanding Shares11,870,000Market Cap$1.61 billion Next Earnings Date5/2/2019 (Estimated) OptionableOptionable Medifast (NYSE:MED) Frequently Asked Questions What is Medifast's stock symbol? Medifast trades on the New York Stock Exchange (NYSE) under the ticker symbol "MED." How often does Medifast pay dividends? What is the dividend yield for Medifast? Medifast declared a quarterly dividend on Thursday, March 14th. Investors of record on Friday, March 29th will be paid a dividend of $0.75 per share on Tuesday, May 7th. This represents a $3.00 annualized dividend and a yield of 2.22%. The ex-dividend date is Thursday, March 28th. View Medifast's Dividend History. How were Medifast's earnings last quarter? Medifast Inc (NYSE:MED) released its quarterly earnings results on Tuesday, February, 26th. The specialty retailer reported $1.30 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $1.21 by $0.09. The specialty retailer had revenue of $145.80 million for the quarter, compared to analyst estimates of $141.86 million. Medifast had a return on equity of 51.04% and a net margin of 11.14%. The business's revenue was up 86.9% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.60 EPS. View Medifast's Earnings History. When is Medifast's next earnings date? Medifast is scheduled to release their next quarterly earnings announcement on Thursday, May 2nd 2019. View Earnings Estimates for Medifast. What guidance has Medifast issued on next quarter's earnings? Medifast updated its FY19 earnings guidance on Tuesday, February, 26th. The company provided earnings per share (EPS) guidance of $6.45-6.65 for the period, compared to the Thomson Reuters consensus estimate of $5.86. The company issued revenue guidance of $700-720 million, compared to the consensus revenue estimate of $653.45 million.Medifast also updated its FY 2019 guidance to $6.45-6.65 EPS. What price target have analysts set for MED? 2 brokers have issued 12-month target prices for Medifast's shares. Their forecasts range from $216.00 to $249.00. On average, they expect Medifast's stock price to reach $232.50 in the next twelve months. This suggests a possible upside of 71.8% from the stock's current price. View Analyst Price Targets for Medifast. What is the consensus analysts' recommendation for Medifast? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medifast in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Medifast. Has Medifast been receiving favorable news coverage? Media headlines about MED stock have been trending neutral this week, according to InfoTrie Sentiment Analysis. InfoTrie ranks the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Medifast earned a news sentiment score of 0.4 on InfoTrie's scale. They also gave press coverage about the specialty retailer a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the company's share price in the immediate future. Who are some of Medifast's key competitors? Some companies that are related to Medifast include MCCORMICK & CO /SH (MKC), Greencore Group (GNCGY), Farmer Bros (FARM), China Marine Food Group (CMFO) and Jammin Java (JAMN). What other stocks do shareholders of Medifast own? Based on aggregate information from My MarketBeat watchlists, some companies that other Medifast investors own include NVIDIA (NVDA), Micron Technology (MU), Alibaba Group (BABA), Boeing (BA), Adobe (ADBE), Mastercard (MA), UnitedHealth Group (UNH), Paypal (PYPL), Align Technology (ALGN) and salesforce.com (CRM). Who are Medifast's key executives? Medifast's management team includes the folowing people: Mr. Daniel R. Chard, CEO & Director (Age 54)Mr. Timothy G. Robinson CPA, CPA, Chief Financial Officer (Age 57)Mr. Bill Baker, Exec. VP of Information Technology (Age 47)Mr. Jason L. Groves, Exec. VP, Gen. Counsel & Corp. Sec. (Age 48)Mr. Tony Tyree, Chief Marketing Officer Who are Medifast's major shareholders? Medifast's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (14.23%), Dimensional Fund Advisors LP (5.50%), Acadian Asset Management LLC (3.62%), MERIAN GLOBAL INVESTORS UK Ltd (2.54%), Principal Financial Group Inc. (1.80%) and Bank of New York Mellon Corp (1.63%). Company insiders that own Medifast stock include Carl E Sassano, Charles P Connolly, Constance J Hallquist, Daniel R Chard, Glenn W Welling, Jeremy John Martin, Michael A Hoer, Michael C Macdonald, Ralph Rushton, Scott Schlackman and Simon TP Ridgway. View Institutional Ownership Trends for Medifast. Which institutional investors are selling Medifast stock? MED stock was sold by a variety of institutional investors in the last quarter, including WINTON GROUP Ltd, O Shaughnessy Asset Management LLC, Prudential Financial Inc., KBC Group NV, Dimensional Fund Advisors LP, SG Americas Securities LLC, Nisa Investment Advisors LLC and Hsbc Holdings PLC. Company insiders that have sold Medifast company stock in the last year include Carl E Sassano, Charles P Connolly, Constance J Hallquist and Scott Schlackman. View Insider Buying and Selling for Medifast. Which institutional investors are buying Medifast stock? MED stock was purchased by a variety of institutional investors in the last quarter, including MERIAN GLOBAL INVESTORS UK Ltd, Millennium Management LLC, Norges Bank, Intrinsic Edge Capital Management LLC, Assenagon Asset Management S.A., Bank of America Corp DE, Principal Financial Group Inc. and First Trust Advisors LP. Company insiders that have bought Medifast stock in the last two years include Daniel R Chard, Michael A Hoer and Simon TP Ridgway. View Insider Buying and Selling for Medifast. How do I buy shares of Medifast? Shares of MED can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Medifast's stock price today? One share of MED stock can currently be purchased for approximately $135.36. How big of a company is Medifast? Medifast has a market capitalization of $1.61 billion and generates $501 million in revenue each year. The specialty retailer earns $55.79 million in net income (profit) each year or $4.62 on an earnings per share basis. What is Medifast's official website? The official website for Medifast is http://www.medifast1.com. How can I contact Medifast? Medifast's mailing address is 100 International Drive, Baltimore MD, 21202. The specialty retailer can be reached via phone at 410-581-8042 or via email at [email protected] MarketBeat Community Rating for Medifast (NYSE MED)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 268 (Vote Outperform)Underperform Votes: 283 (Vote Underperform)Total Votes: 551MarketBeat's community ratings are surveys of what our community members think about Medifast and other stocks. Vote "Outperform" if you believe MED will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MED will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/19/2019 by MarketBeat.com StaffFeatured Article: How the Consumer Price Index (CPI) is calculated?